BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2002
View Archived Issues
Radiopharmaceutical therapy reduces pain with low toxicity in osteosarcoma patients
Read More
Effects on dendritic cell function of the immunomodulator R-848
Read More
Topical application of NF-kB decoy ODN successfully treats atopic dermatitis
Read More
Effective, safe, rapid and long-lasting relief of allergic symptoms achieved with tecastemizole
Read More
GI safety of Merck's new-generation COX-2-selective agent etoricoxib
Read More
Aventis reflects on achievements in 2001
Read More
Hepatoprotective effects of iNOS inhibitor Ono-1714 demonstrated in pig I/R model
Read More
PDE5 inhibitor reduces elevated lower esophageal sphincter tone in humans
Read More
Encouraging results obtained for Vasogen's immune modulation therapy in CHF
Read More
Corixa's Melacine phase III design approved
Read More
D-Pharm earns first milestone payment for SPD-421 from Shire
Read More
Endostatin designated orphan drug in malignant metastatic melanoma
Read More
Inhaled antimicrobial agent to be screened for potential against anthrax
Read More
OrBec receives orphan drug status in Europe for intestinal graft-vs.-host disease
Read More
NDA filed for Zomig Nasal Spray
Read More
Achillion initiates phase II trial of ACH-126443 in HBV
Read More
Oxigene and Peregrine conclude Arcus Therapeutics joint venture
Read More
Procleix HIV-1/HCV NAT assay approved in U.S.
Read More
Potential of new arthroscopy drug validated in phase II clinical trials
Read More
Scientists at Genentech describe c-mpl agonist antibodies
Read More
Tetracycline compounds with antibacterial activity
Read More
Compounds for use in diseases associated with hypercholesterolemia described by BASF
Read More
Histamine H3 receptor ligands reportedly useful for Alzheimer's disease, etc.
Read More
Italian researchers identify compounds with potential in the treatment of HCV infection
Read More
Factor Xa and/or factor VIIa inhibitors in the Merck pipeline
Read More
Roche synthesizes prodrugs of 4-phenylpyridine tachykinin NK1 receptor antagonists
Read More
